The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis

Soluble Axl (sAxl) was recently shown to be strongly released into the blood during liver fibrogenesis and hepatocellular carcinoma suggesting sAxl as a biomarker of liver diseases. In this study we are the first to evaluate sAxl in human serum in comparison to Enhanced Liver Fibrosis (ELF) test and...

Descripción completa

Detalles Bibliográficos
Autores principales: Staufer, Katharina, Dengler, Mirko, Huber, Heidemarie, Marculescu, Rodrig, Stauber, Rudolf, Lackner, Carolin, Dienes, Hans-Peter, Kivaranovic, Danijel, Schachner, Christian, Zeitlinger, Markus, Wulkersdorfer, Beatrix, Rauch, Peter, Prager, Gerhard, Trauner, Michael, Mikulits, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680921/
https://www.ncbi.nlm.nih.gov/pubmed/29072690
http://dx.doi.org/10.1038/cddis.2017.554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680921/
https://www.ncbi.nlm.nih.gov/pubmed/29072690
http://dx.doi.org/10.1038/cddis.2017.554

Ejemplares similares